The positive symptoms of schizophrenia receive the most clinical attention and are the primary targets for pharmacological treatment. Recent studies have focused on studying the negative symptoms and nonpharmacological approaches to cognitive improvement in schizophrenia have demonstrated some positive change. In this patient case and expert consult Q&A session, Dr. John Kane goes in-depth with […]
The positive symptoms of schizophrenia receive the most clinical attention and are the primary targets for pharmacological treatment. Recent studies have focused on studying the negative symptoms and nonpharmacological approaches to cognitive improvement in schizophrenia have demonstrated some positive change. In this patient case and expert consult Q&A session, Dr. John Kane goes in-depth with the case of J.O., and answers questions while offering evidence, guidelines, and quality measures on the cognitive deficits in patients with schizophrenia.
The positive symptoms of schizophrenia receive the most clinical attention and are the primary targets for pharmacological treatment. Recent studies have focused on studying the negative symptoms and nonpharmacological approaches to cognitive improvement in schizophrenia have demonstrated some positive change. In this patient case and expert consult Q&A session, Dr. John Kane goes in-depth with the case of J.O., and answers questions while offering evidence, guidelines, and quality measures on the cognitive deficits in patients with schizophrenia.